Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Neurovirol. 2017 Jan 20;23(3):404–421. doi: 10.1007/s13365-016-0510-z

Figure 3.

Figure 3

DSM-5, Frascati, and Gisslén neurocognitive impairment predicting manifest everyday functioning outcomes in the HIV+ sample (N = 361). Odds ratios (OR; [95% confidence interval]) reflect the increased likelihood for functional impairment given neurocognitive impairment as defined by each system.